Search

Breakthrough findings illustrate the promise of precision oncology and signify a paradigm shift in drug development. Interim data from three trials show a 76 percent confirmed overall response rate in patients treated with the TRK inhibitor.

… Saturday, June 3, 2017 Larotrectinib (LOXO-101) has demonstrated consistent and durable antitumor activity in tropomyosin receptor kinase (TRK) fusion cancers across a wide range of patient ages and tumor types and was well tolerated by patients, according to results from three clinical trials presented

… Full Title Phase 1, Dose-Escalation Study of KTX-2001 (an NSD2 Inhibitor) Alone and in Combination with Darolutamide for Metastatic Castration-Resistant Prostate Cancer Purpose To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for

… Degree MD Email [email protected] Lab Phone 646-888-2796

A study from investigators in the Sloan Kettering Institute uncovers the details of how a key protein called GRP94 becomes disrupted, leading to cancer and other diseases.

… Tuesday, June 30, 2020 Summary A study from investigators in the Sloan Kettering Institute reveals how a protein called GRP94, which is normally a “good guy” in the cell, turns bad when it has a sugar molecule added to it. In molecular biology, chaperones are a class of proteins that help regulate how

Lymphoma experts Anas Younes, MD and Andrew Zelenetz, MD, PhD discuss the fast evolving research on CAR T cells and checkpoint inhibitors that is yielding the novel treatment options improving both outcomes and quality of life for people with lymphoma.

… Lymphoma experts Anas Younes, MD and Andrew Zelenetz, MD, PhD discuss the fast evolving research on CAR T cells and checkpoint inhibitors that is yielding the novel treatment options improving both outcomes and quality of life for people with lymphoma.

… Job Title Research Technician

… Job Title PhD Student, GSK; Geoffrey Beene Graduate Fellow Degree BS Start Year 2024 Email [email protected] Lab Phone 646-888-3857

I am a computer scientist and board-certified pathologist. My clinical work focuses on computational pathology, digital pathology, and clinical informatics for the hematopathology service.

… Pathologist Job Title Director, Artificial Intelligence, Hematopathology Service I am a computer scientist and board-certified pathologist. My clinical work focuses on computational pathology, digital pathology, and clinical informatics for the hematopathology service. My lab focuses on developing artificial

Soy científico de informática y patólogo certificado por la junta. Mi trabajo clínico se centra en la patología computacional, patología digital e informática clínica para el servicio de hematopatología.

… Pathologist Job Title Director del Servicio de Inteligencia Artificial y Hematopatología Soy científico de informática y patólogo certificado por la junta. Mi trabajo clínico se centra en la patología computacional, patología digital e informática clínica para el servicio de hematopatología. Mi trabajo

… Job Title Graduate Student